Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. De Leyn P, Dooms C, Kuzdzal J, Lardinois D, Passlick B, Rami-Porta R, Turna A, Van Schil P, Venuta F, Waller D, Weder W, Zielinski M (2014) Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg 45(5):787–798
2. National comprehensive cancer network. NCCN clinical practice guidelines in oncology. Non-small cell lung cancer. https://www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Accessed 7 Feb 2023
3. Suzuki K, Nagai K, Yoshida J, Nishimura M, Takahashi K, Nishiwaki Y (1999) The prognosis of surgically resected N2 non-small cell lung cancer: the importance of clinical N status. J Thorac Cardiovasc Surg 118(1):145–153
4. Vansteenkiste JF, De Leyn PR, Deneffe GJ, Stalpaert G, Nackaerts KL, Lerut TE, Demedts MG (1997) Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases Leuven Lung Cancer Group. Ann Thorac Surg 63(5):1441–1450
5. Liu CY, Hung JJ, Wang BY, Hsu WH, Wu YC (2013) Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer. Eur Respir J 41(3):649–655
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献